BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4033726)

  • 1. Antitrust enforcement in health care. Ten years after the AMA suit.
    Costilo LB
    N Engl J Med; 1985 Oct; 313(14):901-4. PubMed ID: 4033726
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitrust law and the physician entrepreneur.
    Relman AS
    N Engl J Med; 1985 Oct; 313(14):884-5. PubMed ID: 4033717
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians under siege: the Federal Trade Commission versus the physicians of St. Francis Hospital.
    Rosen BF
    Med Staff Couns; 1988; 2(4):73-6. PubMed ID: 10290186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitrust and physician payment.
    Pollard MR
    N C Med J; 1984 Apr; 45(4):227-31. PubMed ID: 6585668
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives. Wakened FTC worries providers.
    Mcgraw Hills Med Health; 1988 Apr; 42(14):suppl 4 p.. PubMed ID: 10286492
    [No Abstract]   [Full Text] [Related]  

  • 6. Trade restraint suit filed against AMA.
    Med World News; 1983 Aug; 24(15):74. PubMed ID: 10261843
    [No Abstract]   [Full Text] [Related]  

  • 7. "Free choice" as a restraint of trade in American health care delivery and insurance.
    Weller CD
    Spec Law Dig Health Care (Mon); 1985 May; 7(3):5-46. PubMed ID: 10300085
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitrust in health care.
    Boland JM
    Colo Med; 1982 Mar; 79(3):116-8. PubMed ID: 6896026
    [No Abstract]   [Full Text] [Related]  

  • 9. The antitrust swamp: how can healthcare professionals avoid it?
    Weller CD
    Healthc Financ Manage; 1982 Oct; 36(10):26-8, 30-6. PubMed ID: 10315211
    [No Abstract]   [Full Text] [Related]  

  • 10. The sleeping giant awakens: the physician and the antitrust laws.
    Hirsh HL
    Leg Med; 1985; ():334-56. PubMed ID: 3835424
    [No Abstract]   [Full Text] [Related]  

  • 11. Provider-sponsored ADSs: reducing antitrust liability after Maricopa.
    Walsh JH; Feller H
    Spec Law Dig Health Care (Mon); 1985 Apr; 7(2):5-25. PubMed ID: 10270877
    [No Abstract]   [Full Text] [Related]  

  • 12. Historic Supreme Court decisions make clear that health care area is subject to antitrust scrutiny.
    Employee Benefit Plan Rev; 1982 Aug; 37(2):8-10. PubMed ID: 10259394
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitrust and the new health care delivery environment.
    Waxman JM
    Health Law Vigil; 1982 Nov; 5(23):supply 1-2. PubMed ID: 10257143
    [No Abstract]   [Full Text] [Related]  

  • 14. Here comes the FTC again.
    Hunt K
    Med Econ; 1983 Mar; 60(5):32, 37-8, 42 passim. PubMed ID: 10258812
    [No Abstract]   [Full Text] [Related]  

  • 15. AMA hits FTC intrusion.
    Fisher MJ
    Natl Underwrit Life Health; 1982 Sep; 86(38):1, 22. PubMed ID: 10257624
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitrust in the health services industry: the first five years.
    Dolan AK
    Health Med Care Serv Rev; 1981-1982; 3(2-3):13, 15-24. PubMed ID: 10299261
    [No Abstract]   [Full Text] [Related]  

  • 17. The business of medicine: problems with the corporate practice doctrine.
    Rosoff AJ
    Spec Law Dig Health Care (Mon); 1988 Aug; 9(14):7-25. PubMed ID: 10288326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Court shoots down antitrust immunity.
    Brown M; Nickles PJ
    Mod Healthc; 1982 Aug; 12(8):164-8. PubMed ID: 10256369
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitrust--a deregulation prospect.
    Fried JM
    Issues Health Care; 1982; 3(1):50-5. PubMed ID: 10255624
    [No Abstract]   [Full Text] [Related]  

  • 20. The corporate practice doctrine: is it still viable?
    Manger JA; Cowell LJ
    Healthspan; 1989 Apr; 6(4):3-10. PubMed ID: 10303451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.